OTETREVI
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 May 2024)
What this means for you
This application is over — abandoned 06 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97599396
- Mark type
- Stylized text
- Filed
- 20 Sept 2022
- Published for opposition
- 08 Aug 2023
- Abandoned
- 06 May 2024
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio-metabolic diseases and disorders
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 06 May 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 06 May 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2023 — PUBLISHED FOR OPPOSITION
- 19 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jun 2023 — ASSIGNED TO EXAMINER
- 05 Oct 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Sept 2022 — NEW APPLICATION ENTERED